Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-061373
Filing Date
2023-03-06
Accepted
2023-03-06 16:07:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d461728dsc13ga.htm SC 13G/A 33329
  Complete submission text file 0001193125-23-061373.txt   34796
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42217 | Film No.: 23708956
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
DENNY GEORGE P III (Filed by) CIK: 0001234956 (see all company filings)

Type: SC 13G/A